Cue Biopharma Inc. CUE shares surged 67.57% overnight to $24.70 on Thursday after the company simultaneously announced a $30 ...
A competitor's setback was Xeris Biopharma's (NASDAQ: XERS) gain on Hump Day. On news that a potential commercial threat to one of its three commercialized drugs had been neutralized (at least for now ...
It wasn't because of any news coming from the biotech. Rather, a rival's setback brought the bulls into its stock. A competitor's setback was Xeris Biopharma's (NASDAQ: XERS) gain on Hump Day. On news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results